Engagement models
Flexible engagement models for your clinical trials
With IQA, you have access to the most innovative, flexible and accommodating engagement models that align perfectly with your studies
Today concluding a clinical trial successfully involves a lot of pieces including patient centricity, agile process, technological prowess, cost and scale. With IQA, pharma companies and CROs can leverage unique and customized engagement models that suit the requirements of their evolving clinical development. You can gain greater confidence our partnership of creating value through a methodical approach to clinical trials. Our philosophy involves understanding the sponsor’s needs, identify best-fit offerings and support closer collaboration in order to establish genuine mutually beneficial partnerships.
Any industry as dynamic as life sciences require organizations to be extra proactive to keep up with the regular changes in the market. The best way for pharma and biotech companies to do that is by having an army of skilled resources with expertise across all phases of drug development process. That is exactly what you will get with IQA as your Functional Service Provider (FSP).
Our biometric resources will integrate with your existing teams and processes to give you added advantage and control over the demands of a successful clinical development. Our staffing solutions featuring biostatisticians, statistical programmers and data managers will enable you to enhance your studies within a cost-effective budget.
Benefits of IQA’s FSP engagement model
Completing clinical studies on time and under budget are two major preferences for any pharma and life sciences organization. With IQA’s Fixed Price engagement model, you can experience the flexibility to customize your clinical study the way you want to without the hassle of resource utilization and stress over planning. Our engagement model will accommodate your scope changes while keeping the clinical trial well within the budget.
IQA’s Fixed Price engagement model will empower you to move your clinical development with agility and full transparency. We ensure that your clinical research deliverables are on time through agile SCRUM project management methodology.
Benefits of IQA’s Fixed Price engagement model
Sponsors and CROs often struggle with budget overshoots, multiple functions and systems, and overall inefficiencies. It could lead to delays and piling operational changes. By partnering with IQA through a Time & Material model you can keep your budget and research under control while taking advantage of our full biometrics services with high quality and reliability.
IQA’s expertise ranges across the clinical development lifecycle for multiple therapeutic areas. We have a very strong team of biostatisticians, statistical programmers and data managers who are overlooked by robust governance and ethical policies.
Benefits of IQA’s Time & Material model:
When pharma and biotech companies outsource their clinical research, they usually lose control of the study through inefficient communication and unreliable teams. Through IQA’s Hybrid model, you get access to our complete Biometrics expertise. We will deploy a team of your choice onshore at your location. IQA, on the other hand, will provide offshore support that will effectively keep cost under control while you retain complete control.
IQA’s wide resource pool features skilled biostatisticians, statistical programmers and data managers with experience across therapeutic areas. Our teams – both onshore and offshore – are hired keeping in mind the long-term commitment to your study.
Benefits of IQA’s Hybrid model:
IQA has decades of experience in applying the latest statistical methods and techniques to enhance clinical studies. Our team of biostatisticians continuously work towards keeping themselves updated of regulatory revisions, key industry updates and innovations in the space of technology. Our approach includes tight collaboration with our clients to understand their study specificities and design an ideal solution.